SCHEMBL31335403

SCHEMBL31335403

O=C/C=C/c1ccc(C(F)(F)F)c(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.44
NOTUM Q6P988 1/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
CCNB2 O95067 2/20 0.40
CDK1 P06493 2/20 0.40
CDK4 P11802 2/20 0.40
CCNB1 P14635 2/20 0.40
CCND1 P24385 2/20 0.40
CCNB3 Q8WWL7 2/20 0.40
KIF11 P52732 1/20 0.39
TRPA1 O75762 2/20 0.38
LMNA P02545 1/20 0.38
ALOX5 P09917 1/20 0.38
MAPK1 P28482 1/20 0.38
GABBR2 O75899 1/20 0.38
GABBR1 Q9UBS5 1/20 0.38
APP P05067 2/20 0.36
VCP P55072 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31335389 0.83 NOTUM (0.37) NOTUMKIF11TRPA1APPVCP
SCHEMBL7147339 0.82 KIF11 (0.51) NOTUMALDH1A1KDM4EKIF11APP
SCHEMBL29417742 0.82 KIF11 (0.51) NOTUMALDH1A1KDM4EKIF11APP
SCHEMBL21402590 0.81 KIF11 (0.56) XDHALDH1A1KDM4EMAPTCCNB2
SCHEMBL21996031 0.77 XDH (0.46) XDHALDH1A1KDM4EMAPTCCNB2
SCHEMBL30799215 0.77 XDH (0.46) XDHALDH1A1KDM4EMAPTCCNB2
SCHEMBL16241693 0.77 AKR1C3 (0.57) NOTUMALDH1A1KDM4EMAPTLMNA
SCHEMBL16241694 0.77 AKR1C3 (0.57) NOTUMALDH1A1KDM4EMAPTLMNA
SCHEMBL21676111 0.77 VCP (0.57) XDHALDH1A1KDM4EMAPTCCNB2
SCHEMBL18420271 0.76 NPFFR1 (0.48) XDHNOTUMALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4719605-A1 CHEMICAL COMPOUNDS AND USES THEREOF GlaxoSmithKline Intellectual Property (No.4) Limited (GB) 2026-04-08 EP disclosed
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (GB) 2026-01-15 US disclosed
WO-2024246862-A1 CHEMICAL COMPOUNDS AND USES THEREOF GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) LIMITED (GB) 2024-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF WRN, MSH2, MSH6 XDH 962/4885NOTUM 3318/4885ALDH1A1 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.